Dianthus Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $51.1M | $22.8M | $132.3M | $15.4M | $131.7M | $58.2M | $65.1M | $58.3M |
| Accounts Receivable | $52.0K | $0 | $294.0K | $4.7M | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $409.4M | $280.9M | $177.5M | $82.0M | $180.7M | $151.5M | $149.8M | $145.3M |
| Property, Plant & Equipment | $296.0K | $194.0K | $185.0K | $142.0K | $7.5M | $8.3M | $9.9M | $10.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $530.9M | $374.0M | $179.4M | $83.1M | $189.9M | $161.6M | $161.5M | $157.3M |
| Liabilities | ||||||||
| Accounts Payable | $9.7M | $4.6M | $2.6M | $1.2M | $3.0M | $3.8M | $2.8M | $3.5M |
| Total Current Liabilities | $30.7M | $18.5M | $9.6M | $8.2M | $10.9M | $11.4M | $14.1M | $10.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $37.5M | $21.5M | $10.5M | $9.5M | $17.3M | $17.7M | $20.3M | $11.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-336.7M | $-174.4M | $-89.4M | $-45.9M | $-325.6M | $-254.4M | $-179.5M | $-102.7M |
| Total Stockholders' Equity | $493.4M | $352.5M | $168.9M | $-44.4M | $-17.2M | $143.9M | $141.2M | $145.6M |